Search

Your search keyword '"Vitamin K/antagonists & inhibitors"' showing total 38 results

Search Constraints

Start Over You searched for: Descriptor "Vitamin K/antagonists & inhibitors" Remove constraint Descriptor: "Vitamin K/antagonists & inhibitors"
38 results on '"Vitamin K/antagonists & inhibitors"'

Search Results

1. Trends in utilization of warfarin and direct oral anticoagulants in older adult patients with atrial fibrillation.

2. Vitamin K2 Dependent Matrix Gla Protein Relating to Abdominal Aortic Aneurysm and Overall Mortality:A Combined Case Control and Cohort Study

Catalog

Books, media, physical & digital resources

3. All-Cause Mortality and Cardiovascular Outcomes With Non-Vitamin K Oral Anticoagulants Versus Warfarin in Patients With Heart Failure in the Food and Drug Administration Adverse Event Reporting System

4. Trends and Predictors of Oral Anticoagulation in Patients with Atrial Fibrillation: A Serial Cross-Sectional Study from 2011 to 2016

5. Preventability of serious thromboembolic and bleeding events related to the use of oral anticoagulants

6. What's New in Anticoagulation.

7. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

8. Pharmacokinetics and Pharmacodynamics of Oral Anticoagulants used in Atrial Fibrillation

9. Nonvitamin K Oral Anticoagulants in Patients With Atrial Fibrillation and Severe Renal Dysfunction

10. Cardioversion of atrial fibrillation in a real-world setting:non-vitamin K antagonist oral anticoagulants ensure a fast and safe strategy compared to warfarin

11. Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in 'real-world' atrial fibrillation patients:A comparison with optimally acenocoumarol anticoagulated patients

12. Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation

13. The role of kidney transplantation and phosphate binder use in vitamin K status

14. Real-world clinical evidence on rivaroxaban, dabigatran, and apixaban compared with -vitamin K antagonists in patients with non-valvular atrial fibrillation: a systematic literature review

15. Recanalization Therapies in Acute Ischemic Stroke Patients Impact of Prior Treatment With Novel Oral Anticoagulants on Bleeding Complications and Outcome A Pilot Study

16. Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol

17. Modern Treatment Modalities and Duration of Treatment for Venous Thromboembolism

18. Thromboembolic and major bleeding events in relation to perioperative bridging of vitamin K antagonists in 649 fast-track total hip and knee arthroplasties

19. Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis

20. News in angiology and hemostasis

21. Cancer risk in long-term users of vitamin K antagonists: A population-based case-control study

22. New oral antithrombotics: a need for laboratory monitoring. Against

23. Initiation of glucose-lowering treatment decreases international normalized ratio levels among users of vitamin K antagonists: a self-controlled register study

24. Pharmacoepidemiological assessment of drug interactions with vitamin K antagonists

25. Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillation

26. Dynamics of vitamin K antagonist and new oral anticoagulants use in atrial fibrillation: a Danish drug utilization study

27. Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel

28. Double-blind studies are not always optimum for evaluation of a novel therapy: the case of new anticoagulants

29. Hémostase : nouveaux anticoagulants oraux : de la théorie à la pratique

30. Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism

31. Scuba diving and portal vein thrombosis: a case report

32. The novel anticoagulants: entering a new era

33. Venous thromboembolism: contemporary diagnostic and therapeutic aspects

34. Change in International Normalized Ratio Among Patients Treated With Dicloxacillin and Vitamin K Antagonists

36. Anticoagulants in heart disease : current status and perspectives

37. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes